SCHEMBL30697227

SCHEMBL30697227

[2H]C([2H])([2H])OC(C)(C)CNc1nnc(-c2ccc(Cl)cc2O)c2ccncc12

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.37
PRKCH P24723 5/20 0.36
PRKCQ Q04759 5/20 0.36
PRKCE Q02156 4/20 0.36
PRKCD Q05655 4/20 0.36
KDR P35968 6/20 0.34
IL1B P01584 3/20 0.34
PRKCB P05771 2/20 0.32
FLT1 P17948 2/20 0.32
ROCK2 O75116 2/20 0.32
ROCK1 Q13464 2/20 0.32
PKN1 Q16512 2/20 0.32
PKN2 Q16513 2/20 0.32
PRKCA P17252 1/20 0.32
TTK P33981 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
LATS1 O95835 1/20 0.30
LATS2 Q9NRM7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24379593 0.93 NLRP3 (0.39) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL24379643 0.89 TTK (0.36) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL29875211 0.89 NLRP3 (0.36) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL30571301 0.87 KDR (0.38) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL29875272 0.86 PRKCH (0.33) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL24379633 0.86 NLRP3 (0.40) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL24379625 0.82 NLRP3 (0.38) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL32660756 0.82 KDR (0.37) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL24379571 0.82 KDR (0.37) NLRP3PRKCHPRKCQPRKCEPRKCD
SCHEMBL24379641 0.81 KMT2A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117510495-A Pyridazine compounds for inhibiting NLRP3 万特斯治疗美国公司 2024-02-06 CN disclosed
CN-117500792-A Pyridazine compounds for inhibiting NLRP3 万特斯治疗美国公司 2024-02-02 CN disclosed